Home > Insider Trading > Filing (0001225208-16-038204)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1305253	Eiger Biopharmaceuticals Inc.	EIGR	Biological Products, (No Disgnostic Substances) (2836)	361004130

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1400245	Vivo Ventures Vi Affiilates Fund, L.p.	575 High St Palo Alto CA 94301	No	No	Yes	No
1469473	Vivo Ventures Fund Vi, L.p.	575 High St Palo Alto CA 94301	No	No	Yes	No
1469547	Vivo Ventures Vi, Llc	575 Hight Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-18	186,136	$16.00	1,774,096	No	4	P	Indirect	By Vivo Ventures Fund VI, L.P.
Common Stock	Acquisiton	2016-08-18	1,364	$16.00	12,996	No	4	P	Indirect	By Vivo Ventures VI Affiliates Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Vivo Ventures Fund VI, L.P.
No	4	P	Indirect	By Vivo Ventures VI Affiliates Fund, L.P.

Footnotes

Shares are held by Vivo Ventures Fund VI, L.P. ("Fund VI"). Vivo Ventures VI, LLC, the sole general partner of Fund VI, may be deemed to be the beneficial owner of the shares held by Fund VI. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by Fund VI, except to the extent of its pecuniary interest therein.
Shares are held by Vivo Ventures VI Affiliates Fund, L.P. ("VI Affiliates Fund"). Vivo Ventures VI, LLC, the sole general partner of VI Affiliates Fund, may be deemed to be the beneficial owner of the shares held by VI Affiliates Fund. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by VI Affiliates Fund, except to the extent of its pecuniary interest therein.